Search results
Results from the WOW.Com Content Network
The IATF-EID convened in January 2020 to address the growing viral outbreak in Wuhan, China. [5] They made a resolution to manage the spreading of the new virus, [5] which was known at the time as 2019 novel coronavirus (2019-nCoV) and eventually renamed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. [6]
ISARIC was founded in 2011. [4] In 2012, ISARIC joined with the World Health Organization to launch the Clinical Characterisation Protocol (CCP) program. [5] Its founders cited the 2002–2004 SARS outbreak, 2009 swine flu outbreak and later 2012 MERS outbreak as inciting incidents for the creation of an open source platform for sharing clinical research on emerging infectious diseases.
Emerging Infectious Diseases is a monthly open-access peer-reviewed medical journal published by the Centers for Disease Control and Prevention. [1] The journal is in the public domain [ 2 ] and covers global instances of new and reemerging infectious diseases , putting greater emphasis on disease emergence, prevention , control, and elimination.
ProMED embodied this concept in the sphere of infectious disease reporting since its inception. It is estimated that 70% of emerging human diseases originate in other animal species – termed zoonotic diseases. As diseases in both animal and agriculture species have health implications for humans, ProMED includes posts on emerging animal ...
An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently (in the past 20 years), and could increase in the near future. [ 2 ] [ 3 ] The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or ...
Open Forum Infectious Diseases (OFID) is a peer-reviewed open-access scientific journal focusing on the field of infectious disease. It is operated by the Infectious Diseases Society of America (IDSA) and HIV Medicine Association and published online-only by Oxford University Press. [2] The journal was launched in 2014 with infectious disease ...
The editor-in-chief is infectious disease physician Paul Sax. [ 1 ] According to the Journal Citation Reports , the journal had a 2020 impact factor of 9.079, ranking it 18th out of 162 journals in the category "Immunology", [ 2 ] 3rd out of 92 journals in the category "Infectious Diseases" [ 3 ] and 12th out of 137 journals in the category ...
The lab is part of a national network of secure facilities that study infectious diseases, whether naturally occurring or introduced through bioterrorism. NEIDL is one of only 13 operational or planned biosafety level 4 (BSL-4) laboratories in the United States. NEIDL's current director is Nancy Sullivan, ScD.